Clinical Trial

Health Electronic Assessment of Risks and Trends Using Biometric Equipment and Technology

Study acronym: HEARTBEAT
Recruiting
View on ClinicalTrials.gov →
Summary
This is a phase 0, non-interventional, longitudinal, electronic data capture (EDC) study to facilitate the HEARTBEAT Study project has set out to explore the potential use of smartwatches in collecting and analyzing biometric data to improve the detection, identification, and understanding of cardiovascular diseases and related conditions by SAMSUNG and Tulane. The study will include up to ten thousand adult subjects tasked with wearing a smartwatch to collect digital biomarker data over a 1 year period. Concurrent to smartwatch data collection, subjects will be instructed to complete questionnaires via the Huma Decentralized Clinical Trials (HUMADCT) platform. There are no investigational drugs or interventions administered as part of this study.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-12-21; most recent amendment 2026-03-03.
Trial Details
NCT Number NCT06753045
Lead Sponsor Tulane University
Collaborators: Samsung Electronics
Conditions Heart Diseases
Enrollment 10,000 participants
Start Date 2024-10-08
Primary Completion 2027-10 (estimated)
Study Completion 2027-10 (estimated)
Updated on ClinicalTrials.gov 2026-03-05